Literature DB >> 32288974

The role of infection in asthma.

J Pinto Mendes.   

Abstract

This paper reviews the impact of infections on the onset and clinical course of bronchial asthma. A just emphasis is given to the role viral infections, particularly rhinovirus infections, play in exacerbations, and that played by respiratory syncytial virus, suspected of triggering the asthmatic syndrome. The mechanisms of the immune response to virus attacks are explained, highlighting the asthmatic and allergic patient's weakened response, particularly in the perinatal period. Further stressed is a potentiating effect of viral aggression on the allergic response. The hygiene hypothesis and its lack of scientific consistency is detailed, at least as far as the role it seeks to confer on an unproven antagonism of the Th1 and Th2 lymphocyte responses. The current importance of research not into bacteria, but into bacterial products, including endotoxins, on the modulation of asthma and allergy is noted. Studies which, along these lines, show an environmental impact on genetic secretion in the phenotype are underlined. Also discussed in passing are several mechanisms which go towards explaining neutrophilic asthma - for many a contradiction, given eosinophilia's stranglehold on asthmatic inflammation.
© 2008 Sociedade Portuguesa de Pneumologia.

Entities:  

Keywords:  Asthma and infection; asthma and virus; endotoxins

Year:  2012        PMID: 32288974      PMCID: PMC7129468          DOI: 10.1016/S2173-5115(08)70297-5

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN: 0873-2159


  108 in total

Review 1.  Does environmental endotoxin exposure prevent asthma?

Authors:  J Douwes; N Pearce; D Heederik
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 2.  Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target.

Authors:  Stephen T Holgate
Journal:  J Allergy Clin Immunol       Date:  2006-09       Impact factor: 10.793

Review 3.  Viruses in asthma exacerbations.

Authors:  Wan C Tan
Journal:  Curr Opin Pulm Med       Date:  2005-01       Impact factor: 3.155

4.  Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma.

Authors:  K Grünberg; M C Timmers; E P de Klerk; E C Dick; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

5.  Is the prevalence of wheeze in children altered by neonatal BCG vaccination?

Authors:  Mary F Linehan; Timothy L Frank; Michelle L Hazell; Helen C Francis; Julie A Morris; David N Baxter; Robert M Niven
Journal:  J Allergy Clin Immunol       Date:  2007-03-26       Impact factor: 10.793

6.  Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms.

Authors:  Kristiina Malmström; Anne Pitkäranta; Olli Carpen; Anna Pelkonen; L Pekka Malmberg; Markku Turpeinen; Merja Kajosaari; Seppo Sarna; Harry Lindahl; Tari Haahtela; Mika J Mäkelä
Journal:  J Allergy Clin Immunol       Date:  2006-06-21       Impact factor: 10.793

7.  Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

Authors:  Nele Sigurs; Per M Gustafsson; Ragnar Bjarnason; Fredrik Lundberg; Susanne Schmidt; Fridrik Sigurbergsson; Bengt Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

8.  Respiratory morbidity 20 years after RSV infection in infancy.

Authors:  M Korppi; E Piippo-Savolainen; K Korhonen; S Remes
Journal:  Pediatr Pulmonol       Date:  2004-08

Review 9.  CD14, endotoxin, and asthma risk: actions and interactions.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-07

10.  Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.

Authors:  Merci M H Kusel; Nicholas H de Klerk; Tatiana Kebadze; Vaike Vohma; Patrick G Holt; Sebastian L Johnston; Peter D Sly
Journal:  J Allergy Clin Immunol       Date:  2007-03-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.